Evaluation of opioid induced nausea and vomiting in sickle cell disease

American Journal of Hematology

Volumn 83, Issue 3, 2008, Pages 196-199

  Shord, Stacy Shifflett ^a   Chew, Lita ^a   Villano, John ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; FOLIC ACID; HYDROMORPHONE; HYDROXYUREA; METOCLOPRAMIDE; MORPHINE; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROCHLORPERAZINE; PROMETHAZINE;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; AVASCULAR NECROSIS; CEREBROVASCULAR ACCIDENT; CHOLECYSTECTOMY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DEMOGRAPHY; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; MALE; NAUSEA; OPIOID INDUCED EMESIS; PAIN ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; STATISTICAL ANALYSIS; ULCER; VOMITING;

ADULT; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; HUMANS; NAUSEA; PAIN; PAIN MEASUREMENT; PATIENT SELECTION; RETROSPECTIVE STUDIES; VOMITING;

EID: 39749143297     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21031     Document Type: Article

References (18)

1. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med 1991;325:11-16.
2. Yale SH, Nagib N, Guthrie T. Approach to the vaso-occlusive crisis in adults with sickle cell disease. Am Fam Physician 2000;61:1349-1356, 1363-1344.
3. Campora E, Merlini L, Pace M, et al. The incidence of narcotic-induced emesis. J Pain Symptom Manage 1991;6:428-430.
4. Aparasu R, McCoy RA, Weber C, et al. Opioid-induced emesis among hospitalized nonsurgical patients: Effect on pain and quality of life. J Pain Symptom Manage 1999;18:280-288.
5. Walder B, Schafer M, Henzi I, Tramer MR. Efficacy and safety of patient-controlled opioid analgesia for acute postoperative pain. A quantitative systematic review. Acta Anaesthesiol Scand 2001;45:795-804.
6. Aapro M. Optimising antiemetic therapy: What are the problems and how can they be overcome? Curr Med Res Opin 2005;21:885-897.
7. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350:2441-2451.
8. Cepeda MS, Farrar JT, Baumgarten M, et al. Side effects of opioids during short-term administration: Effect of age, gender, and race. Clin Pharmacol Ther 2003;74:102-112.
9. Chou WY, Wang CH, Liu PH, et al. Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy. Anesthesiology 2006;105:334-337.
10. Ross JR, Rutter D, Welsh K, et al. Clinical response to morphine in cancer patients and genetic variation in candidate genes. Pharmacogenomics J 2005;5:324-336.
11. Ikeda K, Ide S, Han W, et al. How individual sensitivity to opiates can be predicted by gene analyses. Trends Pharmacol Sci 2005;26:311-317.
12. Bhasker CR, McKinnon W, Stone A, et al. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: Ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 2000;10:679-685.
13. Anie KA, Steptoe A. Pain, mood and opioid medication use in sickle cell disease. Hematol J 2003;4:71-73.
14. ASHR Therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. Am J Health Syst Pharm 1999;56:729-764.
15. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003;97:62-71. Table of contents.
16. Milne RW, McLean CF, Mather LE, et al. Influence of renal failure on the disposition of morphine, morphine-3-glucuronide and morphine-6-glucuronide in sheep during intravenous infusion with morphine. J Pharmacol Exp Ther 1997;282:779-786.
17. Mercadante S, Arcuri E. Opioids and renal function. J Pain 2004;5:2-19.
18. Tegeder I, Lotsch J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 1999;37:17-40.